Navigation Links
K-V Pharmaceutical Company to Host Investor Conference Call on May 5, 2010
Date:5/3/2010

>Such factors include (but are not limited to) the following:

  1. the ability to continue as a going concern;
  2. difficulties and uncertainties with respect to obtaining additional capital, as more fully described in Part I, Item 2 — "Management's Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources" in the Quarterly Report on Form 10-Q for the quarter ended June 30, 2009 (the first quarter of fiscal year ending March 31, 2010) (" the Form10-Q");
  3. the consent decree between the Company and the FDA and the Company's suspension of the production and shipment of all of the products that it manufactures and the related nationwide recall affecting all of the products that it manufactures, as well as the related material adverse effect on its revenue, assets and liquidity and capital resources, as more fully described in  Part I, Item 2 — "Management's Discussion and Analysis of Financial Condition and Results of Operations — Background — Discontinuation of Manufacturing and Distribution; Product Recalls; and the FDA Consent Decree" in the Form 10-Q;
  4. the possibility of further reducing the Company's operations, including further reductions of its employee base, and significantly curtailing some or all of its efforts to meet the consent decree's requirements and return its approved products to market in order to maintain and attempt to increase its limited cash and financial resources, and related costs and accounting charges from taking such actions;
  5. the plea agreement between the Company and the U.S. Department of Justice and the Company's obligations in connection therewith, as well as the related material adverse effect, if any, on its revenue, assets and liquidity and capital resources, as more fully described in Note 20 &
    '/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. SynCo Expands Agreement with OncoMed Pharmaceuticals to Manufacture Cancer Stem Cell Antibodies
2. Cumberland Pharmaceuticals To Announce First Quarter 2010 Financial Results on May 13, 2010
3. Althea Technologies Acquires Altus Pharmaceuticals(R) Assets and IP Portfolio, Establishing Technology Platform for Protein Formulations.
4. Addex Pharmaceuticals to Present at BIO Business Forum During the Chicago BIO Convention, May 3rd - 6th, 2010
5. Savient Pharmaceuticals To Hold First Quarter 2010 Results
6. US Oncology Meets With Leading Pharmaceutical and Biotech Companies to Design Clinical Trials for the Cancer Fighting Drugs of Tomorrow
7. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation of Past TOPAMAX(R) Marketing and Promotional Activities
8. Lotus Pharmaceuticals Laevo-Bambuterol Received SFDA Approval to Commence Clinical Trials
9. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Agrees to $75 Million Settlement for Topamax(R) False Claims Lawsuit
10. Renhuang Pharmaceuticals Announces Plans to Introduce Qing Re Jie Du Oral Liquid
11. Jazz Pharmaceuticals to Announce First Quarter 2010 Financial Results on May 5, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is ... Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... fiduciary duties to shareholders. On January 21, ... reporting that Advaxis had misrepresented the clinical data for ...
(Date:1/23/2015)... , Jan. 23, 2015  Now available for sale, ... 7,849,611) support that prevents ankle sprains by cushioning the ... it fits securely around the outside of any shoe ... & comfort while still offering protection against sprains. With ...
(Date:1/23/2015)... , Jan. 23, 2015 Cord Blood America, Inc. ( ... or the "Company")  filed a Preliminary Proxy Statement, Schedule 14A, ... today, and provides an update for shareholders detailing why a ... requested. Dear Shareholders, As we reflect ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4
... CRDC ) today announced that it will release ... 2011, on Monday, February 6, 2012, after the markets close. ... Eastern Time to discuss the financial results and provide an ... Call Details To access the live conference ...
... & Science business of Thomson Reuters announced an ... (IPEA). This partnership provides IPEA,s Direction of Sectorial ... (DISET) branch with access to the Newport ... and tools for sourcing global pharmaceutical ingredients. ...
Cached Medicine Technology:Cardica to Announce Fiscal 2012 Second Quarter Financial Results on Monday, February 6, 2012 2Thomson Reuters Helps Brazil's Institute for Applied Economic Research Identify New Generic Drug Opportunities 2
(Date:1/22/2015)... 22, 2015 A new white paper ... and person-centeredness in the long-term care environment as well ... the continuum. The paper, “The Power of Person-Centeredness in ... and practices of the patient, resident and family experience ...
(Date:1/22/2015)... 22, 2015 Carinsurancesavings.biz has released a new ... and dismemberment insurance . , Purchasing an accidental death ... very advantageous. This type of rider provides benefits if the ... be considered a lesser form of life insurance. , ...
(Date:1/22/2015)... January 23, 2015 Recently, Weddingshe.com has added ... and has announced its highest annual revenues in the past ... its popular glamorous wedding dresses. , According to the sales ... wedding dress promotions for them in 2015. This point can ...
(Date:1/22/2015)... January 22, 2015 EBSCO Information Services ... are expanding their relationship in an effort to further promote ... world. While EBSCO has long made AMA journals available via ... agent for The JAMA Network. , Long known ...
(Date:1/22/2015)... Lower-Auto-Insurance.com has released a new blog post explaining the importance of ... the costs of an auto insurance policy . , Clients ... prices for their vehicle insurance policies. The safety a vehicle offers ... Because of this, drivers should always carry a first aid ...
Breaking Medicine News(10 mins):Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
... lung disease require more than brief smoking cessation ... Health & Science University Smoking Cessation Center report. ... in the online edition of Pulmonary and Critical ... of Physicians. , Although effective treatments for smoking ...
... Holdings,Inc. (NYSE: ZMH ; SWX: ZMH) announced today ... be broadcast live over the Internet on,Thursday, April 24, ... the quarterly results will be made available at 7:00 ... audio webcast can be accessed via Zimmer,s Investor Relations,website ...
... Care are Key Issues Facing State, LOS ANGELES, ... the first of several statewide forums on,Thursday, in which ... the,state,s healthcare infrastructure and potential solutions., The 2008 ... looming,shortage in healthcare workers, the wide disparities in quality ...
... those routinely excluded or under-represented, researchers say , , ... analysis of the American clinical trial process suggests ... routinely excluded or under-represented women, older people, minorities, ... "We,ve got a big problem," said Daniel S. ...
... RATON, Fla., April 1, 2008 Breckenridge announced,today that ... AG to,develop and manufacture a generic ANDA product. Under ... to the U.S. Food and Drug,Administration (FDA) for the ... currently shows U.S. sales of approximately $279 million, and,is ...
... primed them for chemical onslaught and exposed cancer cells, ... Fasting for two days before chemotherapy might protect cancer ... drugs by shielding healthy cells while dooming malignant cells ... of chemotherapy are one of the major obstacles in ...
Cached Medicine News:Health News:Smokers with lung disease need more than 'brief' intervention 2Health News:Report Claims Clinical Trials Miss Many Populations 2Health News:Report Claims Clinical Trials Miss Many Populations 3Health News:Report Claims Clinical Trials Miss Many Populations 4Health News:Fasting Before Chemo Protects Healthy Cells 2Health News:Fasting Before Chemo Protects Healthy Cells 3Health News:Fasting Before Chemo Protects Healthy Cells 4
... average 5:1 increase in usage time at all ... standard cannula. , ,The combination of the ... patients a superior alternative to liquid oxygen. , ... , ,NOTE: Each model ...
... An All-In-One Conserver., ,Offers an average 5:1 ... ,Allows the use of a standard cannula. ... and lightweight cylinders offers ambulatory oxygen patients a ... backed by a 2-year warranty. ...
... average 5:1 increase in usage time at all ... standard cannula. , ,The combination of the ... patients a superior alternative to liquid oxygen. , ... , ,NOTE: Each model ...
... an average 5:1 increase in usage time at ... a standard cannula. , ,The combination of ... oxygen patients a superior alternative to liquid oxygen. ... , ,NOTE: Each ...
Medicine Products: